TCS, HDFCBANK, SBI Liquid Fund (G)
Lincoln Pharmaceuticals Ltd.
Lincoln Pharma
NSE
₹ 0.00
0.00 (0.00)%
Healthcare
Small-cap
With a market cap of ₹18.90L Cr.
Moderate Volatility
Stock is 1.13x as volatile as index
| EX-Date | Purpose |
|---|---|
| 25 05 2021 | LINCOLN PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2021 ,inter alia, to consider and approve the audited standalone and consolidated financial results of the Company for the quarter and year ended on March 31, 2021 and recommendation of dividend on equity shares of the Company, if any, along with any other business, if any. Further, in continuation to our disclosure on closure of trading window dated March 31, 2021, pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015, trading window has been closed for trading in securities of the Company from April 01, 2021 and shall reopen after the expiry of 48 hours from the time the result becomes generally available. |
| 10 08 2021 | Quarterly Results |
| 05 10 2021 | inter-alia to transact the following businesses: 1) To issue/ allot equity shares to the eligible shareholders of Lincoln Parenteral Ltd. pursuant to Scheme of Amalgamation of Lincoln Parenteral Limited ( Transferor Company ) and Lincoln Pharmaceuticals Limited ( Transferee Company ) and their respective shareholders and creditors, under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 as approved by the Hon ble National Company Law Tribunal, Ahmedabad Bench vide its order dated September 14, 2021. 2) Any other item may be taken up for consideration with the permission of the Chairman and with the consent of a majority of the Directors present in the Meeting, if any. |
| 11 11 2021 | Quarterly Results |
| 10 02 2022 | Quarterly Results |
| 19 05 2022 | Dividend |
| 09 08 2022 | Quarterly Results |
| 10 11 2022 | Quarterly Results |
| 09 02 2023 | Quarterly Results |
| 25 05 2023 | Dividend & Audited Results |
| 10 08 2023 | Quarterly Results |
| 02 11 2023 | Quarterly Results |
| 08 02 2024 | Quarterly Results |
| 14 11 2024 | Quarterly Results |
| 13 02 2025 | Quarterly Results |
News
No News data available
